Free tool
Stocks listed on Nasdaq GM
We cover 8 companies listed on Nasdaq GM. The median market value in the group is $1.79B. Across the group, the median move over the past trading day is 0.00%. Price change over the past year runs from −77.3% to +86.6% across the middle 80 percent of the group, with a median of −2.9%.
Other lists in this group
Table
8 of 701 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| SMMT | Summit Therapeutics Inc. | $11.35B | Large cap | −42.63% | Oct 19, 2026 |
| ABVX | ABIVAX Société Anonyme | $10.17B | Large cap | +46.70% | Sep 21, 2026 |
| NRIX | Nurix Therapeutics, Inc. | $2.77B | Mid cap | +179.69% | Oct 8, 2026 |
| ATRC | AtriCure, Inc. | $2.45B | Mid cap | +29.14% | Oct 27, 2026 |
| IVA | Inventiva S.A. | $1.14B | Small cap | −7.84% | Sep 25, 2026 |
| BBNX | Beta Bionics, Inc. | $870.10M | Small cap | +1.95% | Oct 27, 2026 |
| NNOX | Nano-X Imaging Ltd. | $68.83M | Micro cap | −77.77% | Sep 9, 2026 |
| IMMP | Immutep Limited | $56.00M | Micro cap | −77.11% | Sep 2, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.